Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4062241
Max Phase: Preclinical
Molecular Formula: C50H56Na4O11
Molecular Weight: 837.02
Molecule Type: Small molecule
Associated Items:
ID: ALA4062241
Max Phase: Preclinical
Molecular Formula: C50H56Na4O11
Molecular Weight: 837.02
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCOc1c2cc(C(=O)[O-])cc1Cc1cc(C(=O)[O-])cc(c1OCCCCCC)Cc1cc(C(=O)[O-])cc(c1OCCCCCC)Cc1cc(cc(C(=O)[O-])c1)C2.[Na+].[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C50H60O11.4Na/c1-4-7-10-13-16-59-44-34-20-32-19-33(23-40(22-32)47(51)52)21-35-27-42(49(55)56)29-37(45(35)60-17-14-11-8-5-2)25-39-31-43(50(57)58)30-38(46(39)61-18-15-12-9-6-3)24-36(44)28-41(26-34)48(53)54;;;;/h19,22-23,26-31H,4-18,20-21,24-25H2,1-3H3,(H,51,52)(H,53,54)(H,55,56)(H,57,58);;;;/q;4*+1/p-4
Standard InChI Key: YRPDQOUHLLHESJ-UHFFFAOYSA-J
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 837.02 | Molecular Weight (Monoisotopic): 836.4136 | AlogP: 11.03 | #Rotatable Bonds: 22 |
Polar Surface Area: 176.89 | Molecular Species: ACID | HBA: 7 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.64 | CX Basic pKa: | CX LogP: 13.16 | CX LogD: 1.22 |
Aromatic Rings: 4 | Heavy Atoms: 61 | QED Weighted: 0.05 | Np Likeness Score: 0.29 |
1. Sestito SE, Facchini FA, Morbioli I, Billod JM, Martin-Santamaria S, Casnati A, Sansone F, Peri F.. (2017) Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling., 60 (12): [PMID:28471658] [10.1021/acs.jmedchem.7b00095] |
Source(1):